跳至主要内容
临床试验/NCT02022228
NCT02022228Unknown不适用

Dual Trigger With GnRH Agonist and Human Chorionic Gonadotropin for Final Oocyte Maturation in Patients at High Risk of Ovarian Hyperstimulation Syndrome in GnRH Antagonist Protocol

Chenshiling1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2012年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
numbers of patients having OHSS

研究概览

简要总结

Gonadotropin releasing hormone (GnRH) agonist is sufficient for triggering final oocyte maturation in GnRH antagonist protocol and can significantly reduce incidence of ovarian hyperstimulation syndrome (OHSS) in high-risk patients.

However, lower oocyte yield was reported in patients with lower luteinizing hormone (LH) level post trigger with single injection of GnRH agonist, which might be related to the shorter duration and lower amount of LH induced by GnRH agonist.

Our aim is to study dual trigger with GnRH agonist and human chorionic gonadotropin (hCG) for preventing OHSS and maintaining clinical outcome in high risk patients who receive controlled ovarian stimulation in GnRH antagonist protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
— 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with polycystic ovarian syndrome
  • patients with polycystic ovarian morphology on ultrasound
  • patients who previously experienced an ovarian stimulation cycle, with a high response to gonadotrophins

排除标准

  • patients undergoing coasting
  • patients with past ovarian surgery

研究组 & 干预措施

0.2mg triptorelin and 1000 IU hCG

Experimental

Patients were triggered with 0.2mg triptorelin and 1000 IU hCG

干预措施: hCG (Drug)

0.2mg triptorelin and 500 IU hCG

Experimental

Patients were triggered with 0.2mg triptorelin and 500 IU hCG

干预措施: triptorelin (Drug)

0.2mg triptorelin and 500 IU hCG

Experimental

Patients were triggered with 0.2mg triptorelin and 500 IU hCG

干预措施: hCG (Drug)

0.2mg triptorelin and 1000 IU hCG

Experimental

Patients were triggered with 0.2mg triptorelin and 1000 IU hCG

干预措施: triptorelin (Drug)

结局指标

主要结局

numbers of patients having OHSS

时间窗: 2 weeks post trigger with dual GnRHa

clinical pregnancy rate per transfer cycle

时间窗: 1month post embryo transfer

oocyte yield

时间窗: oocyte retrieval day (34 to 38 hours post trigger with GnRHa and hCG)

Oocyte yield was defined as the ratio of the total number of collected oocytes to the number of follicles measuring ≥10 mm on the day of oocyte retrieval.

Oocyte maturity

时间窗: 24 hours post oocyte retrieval day

Oocyte maturity was defined as the ratio of metaphase II (MII) oocytes to the number of collected oocytes in the patients undergoing with intracytoplasmic sperm injection (ICSI).

次要结局

  • serum hCG level 12 hours post trigger(12 hours post trigger)
  • fertilization rate(48 hours post IVF/ICSI)
  • implantation rate(1 month post embryo transfer)
  • serum luteinizing hormone level 12 hours post trigger(12 hours post trigger)

研究者

发起方
Chenshiling
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chenshiling

Professor, M.D., Ph.D.

Nanfang Hospital, Southern Medical University

研究点 (1)

Loading locations...

相似试验